IDEAYA Biosciences, Inc. Common Stock
$37.73
$0.07 (+0.19%)
$37.24Day Range$38.46
Key Statistics
Market Cap
$3.63B
Shares Outstanding
96.5M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
May 23, 2019
Round Lot
100
Locale
US
Trading Data
Day Open
$37.71
Day High
$38.46
Day Low
$37.24
Volume
639.9K
VWAP
$37.71
Prev Close
$37.66
Transactions
--
Acc. Volume
--
About IDEAYA Biosciences, Inc. Common Stock
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275 (Werner Helicase), IDE161 (PARG), and IDE705 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.
PHARMACEUTICAL PREPARATIONSSIC 2834145 employees5000 SHORELINE CT, SUITE 300, SOUTH SAN FRANCISCO, CA, 94080650-443-6209IPO May 23, 2019US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001676725
- Composite FIGI
- BBG00CTZ4D83
- Share Class FIGI
- BBG00CTZ4D92
- Ticker Root
- IDYA
- SIC Code
- 2834
About IDEAYA Biosciences, Inc. Common Stock (IDYA) Stock
IDEAYA Biosciences, Inc. Common Stock (IDYA) closed the 2026-09-16 session at $37.73, up 0.19% versus the previous close (+0.07). The stock opened at $37.71 and traded between $37.24 and $38.46 during that session. Session trading volume was 640K shares. The volume-weighted average price (VWAP) is $37.71.
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275 (Werner Helicase), IDE161 (PARG), and IDE705 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.
IDEAYA Biosciences, Inc. Common Stock has a market capitalization of $3.63 billion. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. IDYA is listed on the XNAS exchange. The company employs approximately 145 people. IDEAYA Biosciences, Inc. Common Stock is headquartered in SOUTH SAN FRANCISCO, CA. The recorded listing date is 2019-05-23.
On this page you can find market IDYA stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.